Growth Metrics

LifeMD (LFMD) Current Deferred Revenue (2018 - 2026)

LifeMD filings provide 8 years of Current Deferred Revenue readings, the most recent being $10.8 million for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue fell 36.84% to $10.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $10.8 million, a 36.84% decrease, with the full-year FY2025 number at $10.8 million, down 36.84% from a year prior.
  • Current Deferred Revenue hit $10.8 million in Q4 2025 for LifeMD, down from $14.4 million in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $20.6 million in Q3 2024 to a low of $1.3 million in Q1 2021.
  • Median Current Deferred Revenue over the past 5 years was $6.1 million (2023), compared with a mean of $8.4 million.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 355.08% in 2021 and later tumbled 36.84% in 2025.
  • LifeMD's Current Deferred Revenue stood at $1.5 million in 2021, then soared by 269.86% to $5.5 million in 2022, then soared by 31.08% to $7.3 million in 2023, then soared by 135.16% to $17.1 million in 2024, then tumbled by 36.84% to $10.8 million in 2025.
  • The last three reported values for Current Deferred Revenue were $10.8 million (Q4 2025), $14.4 million (Q3 2025), and $16.9 million (Q2 2025) per Business Quant data.